Alumis, Inc. (ALMS)
7.06
-0.10
(-1.40%)
USD |
NASDAQ |
Oct 12, 16:00
7.045
-0.02
(-0.21%)
After-Hours: 20:00
Alumis Net Income (TTM) : -438.96M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -438.96M |
| March 31, 2026 | -237.42M |
| December 31, 2025 | -243.32M |
| September 30, 2025 | -245.15M |
| June 30, 2025 | -227.52M |
| March 31, 2025 | -343.35M |
| Date | Value |
|---|---|
| December 31, 2024 | -294.23M |
| September 30, 2024 | -238.77M |
| June 30, 2024 | -189.03M |
| March 31, 2024 | -168.82M |
| December 31, 2023 | -154.99M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 21.04B |
| Corcept Therapeutics, Inc. | 54.20M |
| Aclaris Therapeutics, Inc. | -75.74M |
| BioAge Labs, Inc. | -94.46M |
| ANI Pharmaceuticals, Inc. | 99.95M |